Revolutionizing Cancer Detection with
The True Liquid Biopsy
Quick, Non-Invasive Test with Superior Sensitivity and Specificity
Who We Are
PanGIA Biotech
Welcome to PanGIA Biotech, a leading biotechnology company at the forefront of true liquid biopsy technology. We are dedicated to transforming disease and cancer detection through our innovative and groundbreaking solutions. With our expertise and commitment to research, we aim to make a significant impact by empowering patients and healthcare providers with powerful detection tools.
At PanGIA, our team believes in the power of the true liquid biopsy. Our team of scientists, researchers, and industry experts have developed cutting-edge methods to detect and analyze cancer-related biomarkers in urine. By harnessing the potential of the true liquid biopsy, we can provide accurate, non-invasive, and personalized diagnostic solutions for early cancer detection, treatment selection, and monitoring.
What if it were possible to detect and distinguish different cancers in early-stage disease when response to therapy is greatest,
using a non-invasive urine specimen?
The Solution
True Liquid Biopsy Platform
PanGIA is a white space, urine based, non-invasive, machine learning driven, biomolecular profile true liquid biopsy platform.
Our true liquid biopsy platform allows rapid development of non-invasive testing for detecting and managing a variety of diseases and disorders, including cancers. Our sophisticated algorithms and bioinformatics tools enable the interpretation and extraction of meaningful insights from complex data.
One of the key advantages of our true liquid biopsy technology is its non-invasive nature. Unlike common traditional and liquid biopsies that require invasive procedures, our tests do not require a blood draw or procedure. This minimizes patient discomfort, reduces procedural risks, and allows for serial monitoring of the disease progression and treatment response. Our technology empowers both patients and healthcare professionals with actionable information for informed decision-making.
Our Mission
Early Detection is the CURE
PanGIA Biotech’s true liquid biopsy products are designed to meet the diverse needs of patients, physicians, and researchers. Our solutions are tailored to various cancer types, diseases, and disorders, ensuring accurate and actionable results.
By leveraging state-of-the-art technologies and rigorous quality control processes, the true liquid biopsy tests deliver exceptional sensitivity, specificity, and reliability. Whether you are looking for early cancer detection, therapy selection, monitoring treatment response, or detecting minimal residual disease, our products are designed to support patients throughout the entire journey.
Improved early detection of cancers, especially in early stages (Stage 1-2)
Improve quality of life
Drive wellness through earlier intervention
Patients and clinicians would overwhelmingly prefer a quick, non-invasive test with superior sensitivity and specificity.
Reduce Unnecessary Biopsies
Improve Diagnostic Yield
Reduce Costs
Fewer Complications and Side Effects
PanGIA combines a machine learning algorithm with proprietary unbiased binding of small molecules, proteins, and cells, followed by a signal readout and final analysis, creating a biomolecular profile of the patient.
PanGIA Platform
True Liquid Biopsy Pipeline
PanGIA Prostate
PanGIA Breast
PanGIA Ovarian
PanGIA Lung
PanGIA Renal
PanGIA Bladder
PanGIA Colorectal
PanGIA Stomach
PanGIA Pancreas
PanGIA Liver
PanGIA Brain
& more!
Disruptive Innovation Use Case
PanGIA Platform
PanGIA is a white space, urine based, non-invasive, machine learning driven, biomolecular profile testing platform.
Value to Patients
→ Improved predictive profile over PSA / other screening tests
→ Avoidance or warranted delay of invasive procedures
Value to Physicians
→ Additional data points for identifying candidates for biopsies
→ Improved outcomes from missing fewer cancers and reduced side effects
Value to Payers
→ Avoidance of unnecessary biopsies
→ Avoidance of costs for side effects
